D. E. Shaw Research is a brand at the forefront of computational technologies, revolutionizing the field of drug discovery.

With a focus on designing targeted therapeutics for disease treatment, they leverage their core technologies to reshape the process of drug development. Their special-purpose supercomputers and innovative computational methods allow for an in-depth understanding of the behavior and interactions of biological molecules at an atomic level. This breakthrough technology has uncovered previously unseen biological phenomena and paved the way for precise drug design.

D. E. Shaw Research also conducts extensive research to elucidate the molecular mechanisms behind normal human physiology and pathological conditions.

They aim to identify new strategies for pharmaceutical intervention and develop cutting-edge algorithms for computational chemistry, biology, and Pharmacology. Currently, they have four drugs, including one independently designed, in clinical trials. Located at 120 W.

45th St., 39th Fl., New York, NY, D. E. Shaw Research welcomes inquiries for collaborations and partnerships